Stockreport

Is New Uveal Melanoma Data Elevating Castle Biosciences' DecisionDx-UM Platform Story (CSTL)? [Yahoo! Finance]

Castle Biosciences, Inc. - Common stock  (CSTL) 
Last castle biosciences, inc. - common stock earnings: 3/10 04:05 pm Check Earnings Report
PDF combining its DecisionDx-UM test with PRAME gene expression more accurately predicts metastasis-free and overall survival than next-generation sequencing-based mutation [Read more]